Related Experiment Video
Updated: Jul 17, 2026
03:43
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
Published on: August 22, 2025
Cannabinoids: the separation of central from peripheral effects on a structural basis
1Department of Pharmacognosy, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX, U.K.
Planta Medica
|October 1, 1991
Summary
Cannabinoids show confirmed central activity, with a C-5 hydroxy group conferring potent peripheral effects for potential pain and inflammation drug development.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Drug Development
Background:
- Cannabis and its component cannabinoids have a complex history of therapeutic use and legal challenges.
- Drug development efforts have focused on Delta (1)-tetrahydrocannabinol and its synthetic analogs.
- Ongoing debate exists regarding the central versus peripheral origins of cannabinoid pharmacological effects.
Purpose of the Study:
- To review the therapeutic uses and legal status of cannabis and cannabinoids.
- To discuss drug development from Delta (1)-tetrahydrocannabinol and its synthetic analogues.
- To explore the potential of cannabinoid-based drugs for treating pain, inflammation, and related conditions.
Main Methods:
- Historical review of cannabis and cannabinoid research.
- Discussion of drug development pathways for cannabinoid compounds.
- Analysis of pharmacological data to determine the origin of effects (central vs. peripheral).
Main Results:
- The central activity of cannabinoids has been confirmed.
- The presence of a C-5 hydroxy group on the cannabinoid structure is associated with potent peripheral activity.
- Potential therapeutic applications for pain and inflammation have been identified.
Conclusions:
- Cannabinoid research confirms significant central nervous system activity.
- Structural modifications, specifically a C-5 hydroxy group, enhance peripheral activity.
- Cannabinoid structures hold promise for developing novel therapeutics for pain and inflammation.
Related Concept Videos
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...